Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin recalls around 5.61 lakh pouches of Mibelas 24 Fe in the US
The product, manufactured in India and then supplied in the US market by Lupin Pharmaceuticals, is used to prevent pregnancy
NPPA fixes retail prices of 30 formulations, rejects four applications
Two applications each of Micro Laboratories and Sun Pharma have been deferred by the authority
We have been agile in responding to changing needs of our merchant partners and will continue to do…
Pine Labs is a leading merchant commerce platform. Kush Mehra, Chief Business Officer, Pine Labs talks about its recent launch,…
Specifying Non-Viable Particle Monitoring for Aseptic Processing
Major pharmaceutical companies are investing in new biologics, most of which will be manufactured using aseptic processing.…
Changes to GMP force cleanroom re-classifications
Cleanroom users claiming compliance to cGMP and/or GMP will have to consider a new rule, ISO 14644-1:2015, when next re-qualifying…
Research links COVID-19 to rise in childhood type 1 diabetes
This study analysed data from 30 children in London hospitals diagnosed with new-onset type 1 diabetes during the first peak of…
INST-Mohali develops oral nano-medicines for Kala-Azar and other neglected diseases
According to the INST team, till-date there is no study reported where a combination of two anti-leishmanial drugs has been…
Strides gets USFDA approval for Ursodiol tablets
Product to be launched immediately and marketed by Strides Pharma in the US market
US FDA approves Novartis Kesimpta (ofatumumab) for relapsing forms of MS treatment
Ofatumumab was first approved by the FDA in 2009 for the treatment of chronic lymphocytic leukaemia (CLL)
Researchers develop technology to see inside cells
The new technology may help answer outstanding questions about the immune system, cancer, Alzheimer’s, and more